CLINICAL_TRIALS
trial_result
· 2018-04-17
Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA [Phase 3]
Summary
A Phase 3 study is evaluating the efficacy and safety of ENIA11 in combination with methotrexate versus methotrexate alone in patients with rheumatoid arthritis…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mycenax Biotech Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN